Aleix Prat: How immune fitness can provide valuable insights in breast cancer
Aleix Prat, Director of the Cancer Institute at the Hospital Clinic of Barcelona, shared a post on LinkedIn about a recent paper by him and colleagues, published in ESMO Open:
“Being diagnosed with breast cancer is undoubtedly challenging, but it also presents a unique opportunity to better understand the immune system’s role in health and disease.
Our latest article explores how immune fitness can provide valuable insights in this context.
Cancer immune response meets longevity.
Check it out.”
“Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancer”
Authors: L. Angelats, L. Paré, C. Rubio-Perez, Aleix Prat, F. Brasó-Maristany et al.
Aleix Prat is the Director of the Cancer Institute at the Hospital Clinic of Barcelona, Head of the Translational Genomics Group at IDIBAPS, and a Professor at the University of Barcelona.
He is also a Co-Founder of REVEAL GENOMICS, S.L. His work focuses on breast cancer genomics and the development of omics-based assays for clinical application. His expertise lies in breast cancer and gene expression profiling.
More posts featuring Aleix Prat.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023